Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation
- 1 September 1999
- journal article
- review article
- Published by Wiley in Transplant Infectious Disease
- Vol. 1 (3) , 179-186
- https://doi.org/10.1034/j.1399-3062.1999.010306.x
Abstract
Cytomegalovirus (CMV) continues to be a clinical problem, impairing the overall success rate of transplantation, either through direct involvement of a variety of end-organs or by inducing indirect effects such as graft rejection. We review here how the virus manages to evade host immune responses and replicate extensively in allograft recipients. Recent studies show that the quantity of CMV (viral load) is related directly to the development of CMV disease. We review how clinically significant levels of CMV viral load can be defined and summarize the results of studies showing that a high CMV viral load is the major determinant of CMV disease, explaining the previously reported risk factors of pre-transplant serostatus and the post-transplant detection of CMV viremia.NoteKeywords
This publication has 44 references indexed in Scilit:
- Utility of Urine and Leukocyte Cultures and Plasma DNA Polymerase Chain Reaction for Identification of AIDS Patients at Risk for Developing Human Cytomegalovirus DiseaseThe Journal of Infectious Diseases, 1997
- PATTERNS OF VIREMIA IN LIVER TRANSPLANT RECIPIENTS WITH SYMPTOMATIC CYTOMEGALOVIRUS INFECTIONTransplantation, 1997
- Time to Detection of Cytomegalovirus (CMV) DNA in Blood Leukocytes Is a Predictor for the Development of CMV Disease in CMV-Seronegative Recipients of Allografts from CMV-Seropositive Donors following Liver TransplantationThe Journal of Infectious Diseases, 1996
- The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the CytosolCell, 1996
- Clinical evaluation in organ transplant patients of a polymerase chain reaction test for CMV DNA applied on white blood cells and serumTransplant International, 1994
- PROVISION OF PROGNOSTIC INFORMATION IN IMMUNOCOMPROMISED PATIENTS BY ROUTINE APPLICATION OF THE POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUSTransplantation, 1993
- Polymerase chain reaction in detection of CMV DNA in renal allograft recipientsAustralian and New Zealand Journal of Medicine, 1992
- Preemptive Therapy in Immunocompromised HostsNew England Journal of Medicine, 1991
- The indirect effects of cytomegalovirus infection on the outcome of organ transplantationPublished by American Medical Association (AMA) ,1989
- IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONSThe Lancet, 1987